Sigma Planning Corp Pfizer Inc Transaction History

Sigma Planning Corp

$3.22 Billion
Q3 2024

A detailed history of Sigma Planning Corp transactions in Pfizer Inc stock. As of the latest transaction made, Sigma Planning Corp holds 167,553 shares of PFE stock, worth $4.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

167,553

Previous 167,388 0.1%

Holding current value

$4.6 Million

Previous $4.68 Million 3.52%

% of portfolio

0.15%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $4,570 - $5,179	165 Added 0.1%	167,553 $4.85 Million
Q2 2024 Aug 05, 2024	BUY	$25.26 - $29.6 $47,438 - $55,588	1,878 Added 1.13%	167,388 $4.68 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $2.17 Million - $2.49 Million	83,668 Added 102.23%	165,510 $4.59 Million
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $2.37 Million - $3.08 Million	-90,871 Reduced 52.61%	81,842 $2.36 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $242,536 - $283,500	7,558 Added 4.58%	172,713 $5.73 Million
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $1.06 Million - $1.23 Million	-29,477 Reduced 15.14%	165,155 $6.06 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $975,257 - $1.27 Million	-24,759 Reduced 11.29%	194,632 $7.94 Million
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $89,094 - $116,303	-2,134 Reduced 0.96%	219,391 $0
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $95,396 - $116,455	-2,180 Reduced 0.97%	221,525 $9.69 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $174,627 - $207,053	-3,753 Reduced 1.65%	223,705 $11.7 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $1.27 Million - $1.57 Million	-27,738 Reduced 10.87%	227,458 $11.8 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $164,908 - $244,448	-3,991 Reduced 1.54%	255,196 $15.1 Million
Q3 2021 Oct 28, 2021	BUY	$39.25 - $50.42 $428,099 - $549,930	10,907 Added 4.39%	259,187 $11.1 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $80,438 - $91,123	-2,240 Reduced 0.89%	248,280 $9.72 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $14,132 - $15,938	-422 Reduced 0.17%	250,520 $9.08 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $1.07 Million - $1.36 Million	31,975 Added 14.6%	250,942 $9.24 Million
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $875,855 - $1.03 Million	27,586 Added 14.41%	218,967 $8.04 Million
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $539,268 - $654,212	17,904 Added 10.32%	191,381 $6.26 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $168,802 - $241,181	6,245 Added 3.73%	173,477 $5.66 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $273,499 - $310,386	8,308 Added 5.23%	167,232 $6.55 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $663,803 - $860,758	20,431 Added 14.75%	158,924 $5.71 Million
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $74,699 - $83,870	-2,020 Reduced 1.44%	138,493 $6 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $115,875 - $127,308	3,090 Added 2.25%	140,513 $5.97 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $168,998 - $192,676	-4,393 Reduced 3.1%	137,423 $6 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $9,134 - $11,079	-265 Reduced 0.19%	141,816 $6.25 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $179,609 - $191,481	5,446 Added 3.99%	142,081 $5.16 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $153,838 - $178,473	4,821 Added 3.66%	136,635 $4.85 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $117,141 - $124,291	3,522 Added 2.75%	131,814 $4.77 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $3.98 Million - $4.38 Million	128,292	128,292 $4.58 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Pfizer Inc Transaction History